UK's Unilever has reportedly emerged as the leading bidder for GlaxoSmithKline's (GSK) Indian Horlicks nutrition business. GSK is looking to sell its 72.5% stake in its listed Indian subsidiary GlaxoSmithKline Consumer Healthcare, known for malt-based drinks Horlicks and Boost. The subsidiary has a market value of about ₹30,300 crore ($4.3 billion).